Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Penglai Marine Bio-Tech is a leading Chinese biotechnology company specializing in the research, development, and industrial-scale production of marine-derived nutritional and pharmaceutical ingredients. Founded in 1995 and based in Shandong, the company has established itself as a premier global supplier of glucosamine, chondroitin sulfate, and marine collagen. Their products are widely utilized in the pharmaceutical, nutraceutical, and cosmetic sectors, particularly for joint health and skincare applications. The company operates state-of-the-art manufacturing facilities that comply with international quality standards, including GMP, ISO, and HACCP certifications. Penglai Marine Bio-Tech is a key player in the global supply chain, exporting a significant portion of its output to markets in North America and Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Penglai Marine Bio-Tech.